s-nitroso-n-acetylpenicillamine and Colonic Neoplasms

s-nitroso-n-acetylpenicillamine has been researched along with Colonic Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chun, YJ; Kim, MY; Lee, S; Park, S; Yang, SA	1
Bosia, A; Costamagna, C; Ghigo, D; Miraglia, E; Pescarmona, G; Riganti, C; Viarisio, D	1

Other Studies

2 other study(ies) available for s-nitroso-n-acetylpenicillamine and Colonic Neoplasms

Article	Year
Modulation of CYP3A4 expression by ceramide in human colon carcinoma HT-29 cells. Biochemical and biophysical research communications, 2002, Nov-15, Volume: 298, Issue:5 Topics: Androstadienes; Ceramides; Colonic Neoplasms; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gene Expression; Humans; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligodeoxyribonucleotides, Antisense; omega-N-Methylarginine; Phosphoinositide-3 Kinase Inhibitors; S-Nitroso-N-Acetylpenicillamine; Sphingomyelin Phosphodiesterase; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Wortmannin	2002
Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux. Cancer research, 2005, Jan-15, Volume: 65, Issue:2 Topics: Antibiotics, Antineoplastic; Colonic Neoplasms; Cyclic GMP; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HT29 Cells; Humans; Isoenzymes; Multidrug Resistance-Associated Proteins; Nitrates; Nitric Oxide; Nitric Oxide Synthase; S-Nitroso-N-Acetylpenicillamine	2005

Article

Year

Modulation of CYP3A4 expression by ceramide in human colon carcinoma HT-29 cells.

Biochemical and biophysical research communications, 2002, Nov-15, Volume: 298, Issue:5

Topics: Androstadienes; Ceramides; Colonic Neoplasms; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gene Expression; Humans; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oligodeoxyribonucleotides, Antisense; omega-N-Methylarginine; Phosphoinositide-3 Kinase Inhibitors; S-Nitroso-N-Acetylpenicillamine; Sphingomyelin Phosphodiesterase; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Wortmannin

2002

Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux.

Cancer research, 2005, Jan-15, Volume: 65, Issue:2

Topics: Antibiotics, Antineoplastic; Colonic Neoplasms; Cyclic GMP; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HT29 Cells; Humans; Isoenzymes; Multidrug Resistance-Associated Proteins; Nitrates; Nitric Oxide; Nitric Oxide Synthase; S-Nitroso-N-Acetylpenicillamine

2005